Sialyltransferase

From WikiMD's WELLNESSPEDIA

Sialyltransferase is a type of enzyme that catalyzes the transfer of sialic acid residues to the terminal positions of glycoproteins or glycolipids. This process is crucial in the biosynthesis of glycoconjugates, which play a significant role in various biological processes, including cell-cell interaction, immune response, and pathogen recognition.

Structure and Function[edit]

Sialyltransferases are membrane-bound enzymes that are primarily located in the Golgi apparatus of the cell. They belong to the family of glycosyltransferases and are classified into four types based on the type of linkage they form: α2-3, α2-6, α2-8, and α2-9. Each type of sialyltransferase has a unique substrate specificity and donor substrate preference.

The function of sialyltransferases is to transfer sialic acid residues from the donor substrate, typically cytidine monophosphate (CMP)-sialic acid, to the acceptor substrate, which can be a glycoprotein or glycolipid. This transfer results in the formation of a glycosidic bond between the sialic acid and the acceptor substrate.

Role in Disease[edit]

Abnormal sialylation, caused by the dysregulation of sialyltransferases, has been implicated in several diseases, including cancer, inflammatory diseases, and neurological disorders. In cancer, increased sialylation can lead to enhanced tumor cell invasion and metastasis. In inflammatory diseases, altered sialylation can affect the function of immune cells and contribute to the disease process. In neurological disorders, changes in sialylation can affect neuronal development and function.

Therapeutic Potential[edit]

Given their role in disease, sialyltransferases are considered potential therapeutic targets. Inhibitors of sialyltransferases have been developed and are being investigated for their potential use in the treatment of diseases associated with abnormal sialylation.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.